Trials / Recruiting
RecruitingNCT07263191
A Study of Olanzapine in Participants With Bipolar Disorder.
A Multicenter, Prospective Observational Study to Evaluate Treatment Patterns and Safety in Patients With Bipolar Disorder Taking Olanzapine
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olanzapine | As this is a non-interventional study designed to collect data as part of routine clinical practice, the selection and dosage of medication, treatment period, and whether or not to change it are all based on the clinician's judgment. |
Timeline
- Start date
- 2025-10-30
- Primary completion
- 2027-09-01
- Completion
- 2027-09-01
- First posted
- 2025-12-04
- Last updated
- 2025-12-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07263191. Inclusion in this directory is not an endorsement.